Philippines gives green light to Janssen vaccine trials

MANILA, Philippines — Belgium’s Janssen Pharmaceuticals Inc. becomes the first company to conduct clinical trials for its COVID-19 vaccine in the Philippines, the Food and Drug Administration (FDA) announced yesterday. FDA director general Eric Domingo said the agency approved on Monday Janssen’s application to hold Phase 3 clinical trials in the country. “This has been given the go signal by the FDA and maybe they will be able to start their clinical trial after the New Year,” Domingo said. Janssen, owned by Johnson & Johnson, is among three pharmaceutical firms with pending applications to d…

Read More

HEDGE accordingly